These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3325753)

  • 41. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
    Battershill JM; Fielder RJ
    Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of the bioluminescence assays as screens for genotoxic chemicals.
    Elmore E; Fitzgerald MP
    Prog Clin Biol Res; 1990; 340D():379-87. PubMed ID: 2371306
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of the Ames II and traditional Ames test responses with respect to mutagenicity, strain specificities, need for metabolism and correlation with rodent carcinogenicity.
    Kamber M; Flückiger-Isler S; Engelhardt G; Jaeckh R; Zeiger E
    Mutagenesis; 2009 Jul; 24(4):359-66. PubMed ID: 19447896
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Integrated approach to testing and assessment for predicting rodent genotoxic carcinogenicity.
    Petkov PI; Schultz TW; Donner EM; Honma M; Morita T; Hamada S; Wakata A; Mishima M; Maniwa J; Todorov M; Kaloyanova E; Kotov S; Mekenyan OG
    J Appl Toxicol; 2016 Dec; 36(12):1536-1550. PubMed ID: 27225589
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The results of assays in Drosophila as indicators of exposure to carcinogens.
    Vogel EW; Graf U; Frei HJ; Nivard MM
    IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Overview: industrial perspectives on existing in vivo gene mutation assays.
    Li AP; Kier LD
    Environ Mol Mutagen; 1991; 18(4):292-4. PubMed ID: 1748092
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of high-throughput genotoxicity assays used in profiling the US EPA ToxCast chemicals.
    Knight AW; Little S; Houck K; Dix D; Judson R; Richard A; McCarroll N; Akerman G; Yang C; Birrell L; Walmsley RM
    Regul Toxicol Pharmacol; 2009 Nov; 55(2):188-99. PubMed ID: 19591892
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The use of ex vivo human skin tissue for genotoxicity testing.
    Reus AA; Usta M; Krul CA
    Toxicol Appl Pharmacol; 2012 Jun; 261(2):154-63. PubMed ID: 22507867
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of the GreenScreen GADD45alpha-GFP indicator assay with non-proprietary and proprietary compounds.
    Olaharski A; Albertini S; Kirchner S; Platz S; Uppal H; Lin H; Kolaja K
    Mutat Res; 2009 Jan; 672(1):10-6. PubMed ID: 18812235
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Which rules for assembling short-term test batteries to predict carcinogenicity?
    Benigni R; Giuliani A
    Mol Toxicol; 1987; 1(2-3):143-66. PubMed ID: 3449755
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Approaches for identifying germ cell mutagens: Report of the 2013 IWGT workshop on germ cell assays(☆).
    Yauk CL; Aardema MJ; Benthem Jv; Bishop JB; Dearfield KL; DeMarini DM; Dubrova YE; Honma M; Lupski JR; Marchetti F; Meistrich ML; Pacchierotti F; Stewart J; Waters MD; Douglas GR
    Mutat Res Genet Toxicol Environ Mutagen; 2015 May; 783():36-54. PubMed ID: 25953399
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective.
    Bolt HM; Foth H; Hengstler JG; Degen GH
    Toxicol Lett; 2004 Jun; 151(1):29-41. PubMed ID: 15177638
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of reducing the top concentration used in the in vitro chromosomal aberration test in CHL cells on the evaluation of industrial chemical genotoxicity.
    Morita T; Honma M; Morikawa K
    Mutat Res; 2012 Jan; 741(1-2):32-56. PubMed ID: 22020093
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The use of short term in vitro and submammalian tests as alternatives to large scale animal bioassays.
    Brusick DJ
    Ann N Y Acad Sci; 1983; 406():68-73. PubMed ID: 6576674
    [No Abstract]   [Full Text] [Related]  

  • 55. Environmental mutagenesis and carcinogenesis: test method development, validation and utilization.
    de Serres FJ; Matsushima T
    Mutat Res; 1984 Oct; 130(5):353-9. PubMed ID: 6493256
    [No Abstract]   [Full Text] [Related]  

  • 56. International symposium on short-term tests for genotoxicity. Legislative aspects and selection of appropriate tests for the control of genotoxic potential of a chemical. Pisa, 5-8 April, 1986.
    Sobels FH
    Mutat Res; 1986 Dec; 164(6):389-94. PubMed ID: 3785269
    [No Abstract]   [Full Text] [Related]  

  • 57. The role of Neurospora in evaluating environmental chemicals for mutagenic activity.
    de Serres FJ; Malling HV
    Ann N Y Acad Sci; 1983; 407():177-85. PubMed ID: 6349474
    [No Abstract]   [Full Text] [Related]  

  • 58. Industrial Genotoxicology Group: novel in vivo genotoxicity assays, Royal Society of Medicine, London, UK, December 1992.
    Jones E
    Mutagenesis; 1994 Jan; 9(1):79-80. PubMed ID: 8208135
    [No Abstract]   [Full Text] [Related]  

  • 59. Commentary on the status of short-term tests for chemical carcinogens.
    Shelby MD; Zeiger E; Tennant RW
    Environ Mol Mutagen; 1988; 11(4):437-41. PubMed ID: 3286246
    [No Abstract]   [Full Text] [Related]  

  • 60. The toxicological effects of saccharin in short-term genotoxicity assays.
    Arnold DL; Boyes BG
    Mutat Res; 1989 Sep; 221(2):69-132. PubMed ID: 2671710
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.